MDT Notes
MDT 10K June 24, 2013
leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world. Medtronic was founded in 1949, serves hospitals, physicians, clinicians, and patients in more than 140 countries two operating segments that manufacture and sell device-based medical therapies cardiac and vascular group for cardiac and endovascular disease pacemakers, defibrillator, monitoring devices, Transcatheter Heart Valves, grafts restorative therapies group for spinal, neural, diabetic, and surgical tech implants and products to reduce invasiveness of surgeries
about 10% of net sales on R&D acquired Kanghui - a Chinese manufacturer and distributor of orthopedic products in Nov 2012 entered into exclusive and non-exclusive licenses relating to a wide array of third-party technologies
sell most of our medical devices through direct sales representatives in the U.S. and a combination of direct sales representatives and independent distributors in markets outside the U.S. The three largest markets for our medical devices are the U.S., Western Europe, and Japan. Emerging markets are an area of increasing focus and opportunity as we believe they remain underpenetrated. organize our marketing and sales teams around physician specialties. more than 46,000 employees
Over the last five years, our net sales on a compounded annual growth basis have increased approximately 4 percent, from $14.256 billion in fiscal year 2009 to $16.590 billion in fiscal year 2013
cardiac products - primary competitors in the CRDM business are St. Jude Medical, Inc. (St. Jude), Boston Scientific Corporation (Boston Scientific), Biotronik, Inc., and Sorin Group (Sorin).
thermofisher
Our primary competitors in the Coronary business are Abbott Laboratories (Abbott) and Boston Scientific.
Our primary competitors in the Structural Heart business are Edwards Lifesciences Corporation, St. Jude, Sorin, Maquet
leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world. Medtronic was founded in 1949, serves hospitals, physicians, clinicians, and patients in more than 140 countries two operating segments that manufacture and sell device-based medical therapies cardiac and vascular group for cardiac and endovascular disease pacemakers, defibrillator, monitoring devices, Transcatheter Heart Valves, grafts restorative therapies group for spinal, neural, diabetic, and surgical tech implants and products to reduce invasiveness of surgeries
about 10% of net sales on R&D acquired Kanghui - a Chinese manufacturer and distributor of orthopedic products in Nov 2012 entered into exclusive and non-exclusive licenses relating to a wide array of third-party technologies
sell most of our medical devices through direct sales representatives in the U.S. and a combination of direct sales representatives and independent distributors in markets outside the U.S. The three largest markets for our medical devices are the U.S., Western Europe, and Japan. Emerging markets are an area of increasing focus and opportunity as we believe they remain underpenetrated. organize our marketing and sales teams around physician specialties. more than 46,000 employees
Over the last five years, our net sales on a compounded annual growth basis have increased approximately 4 percent, from $14.256 billion in fiscal year 2009 to $16.590 billion in fiscal year 2013
cardiac products - primary competitors in the CRDM business are St. Jude Medical, Inc. (St. Jude), Boston Scientific Corporation (Boston Scientific), Biotronik, Inc., and Sorin Group (Sorin).
thermofisher
Our primary competitors in the Coronary business are Abbott Laboratories (Abbott) and Boston Scientific.
Our primary competitors in the Structural Heart business are Edwards Lifesciences Corporation, St. Jude, Sorin, Maquet